Oncology Clinical Trials: Successful Design, Conduct, and Analysis
Publié le
Oncology Clinical Trials We wish to draw your attention on the publication of a valuable book Oncology Clinical Trials –…
Biostatistical Challenges of Trials in Rare Diseases
Publié le
Free Webinar on Biostatistical Challenges of Trials in Rare Diseases VIEW RECORDED WEBINAR CONTENTS: In this webinar: We will start by…
IDDI at 6th Oncology Strategy Meeting USA
Publié le
IDDI sponsor and speaker at 6th Oncology Strategy Meeting USA 2018. Join us! Marc Buyse Chief Scientific Officer IDDI will give…
IDDI Sponsor at the Oncology Strategy Meeting 2017
Publié le
Join IDDI at the Oncology Strategy Meeting. IDDI is an oncology CRO led by a highly-skilled biostatistical and clinical team of…
Tumor-Size-Based Measurements as Endpoint in Cancer Clinical Trials
Publié le
Since the early days of clinical cancer research, given the expected direct cytotoxicity of chemotherapy, tumor shrinkage has been used…
Oncology CRO
Publié le
Oncology CRO Providing Full Range of Biostatistics and eClinical Solutions IDDI is an oncology CRO led by a highly-skilled biostatistical…
Design and conduct of Oncology Clinical Trials
Publié le
Buyse M.: Design and conduct of Oncology Clinical Trials: A Session in Memory of Daniel J. Sargent. Invited lecture at…
Current Status of Surrogates for Survival in Cancer Trials
Publié le
IDDI organized a webinar on the Current Status of Surrogates for Survival in Cancer Trials. VIEW THE RECORDING OF THE…
Personalized Cancer Medicine Needs Randomized Trials
Publié le
IDDI organized a webinar on Personalized Cancer Medicine Needs Randomized Trials. Clinical cancer research is undergoing profound changes, mostly because…
Future of Cancer Clinical Trials
Publié le
IDDI organized a webinar on the Future of Cancer Clinical Trials. Cancer clinical trials have been a major determinant of…